Q1 FY2025 Earnings
Financial report interval: 2024.12.31 - 2025.03.31
Overview: Verve Therapeutics(VERV) the Revenue is 32.98 M (+479%);the EBIT is -36.64 M (+35.55%);the EPS is -0.349 (+40.39%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
0.03B479.03%
----
----
EBIT
-0.04B35.55%
----
----
EPS
-0.349540.39%
----
----
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf